About Omnicell
Omnicell is a company based in Mountain View (United States) founded in 1992 by Randy Lipps. It operates as a SaaS (Software-as-a-Service), Professional Services, and HealthTech. Omnicell has raised $20 million across 3 funding rounds from investors including Mariko Osceola Gordon, Sutter Hill Ventures and nassau-capital.com. The company has 3,670 employees as of December 31, 2024. Omnicell has completed 10 acquisitions, including Aesynt, Ateb and FDS Amplicare. Omnicell offers products and services including MedVision, Robotics, Smart Devices, and Services. Omnicell operates in a competitive market with competitors including GE Healthcare, Cureatr, Phil, RIMSYS and Healthera, among others.
- Headquarter Mountain View, United States
- Employees 3670 as on 31 Dec, 2024
- Founders Randy Lipps
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Omnicell, Inc.
-
Annual Revenue
$1.11 B (USD)-3.04as on Dec 31, 2024
-
Net Profit
$12.53 M (USD)0as on Dec 31, 2024
-
EBITDA
$95.25 M (USD)24.95as on Dec 31, 2024
-
Total Equity Funding
$20 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Sutter Hill Ventures
& 4 more
-
Employee Count
3670
as on Dec 31, 2024
-
Investments & Acquisitions
Aesynt
& 9 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Omnicell
Omnicell is a publicly listed company on the NASDAQ with ticker symbol OMCL in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Omnicell
Omnicell offers a comprehensive portfolio of products and services, including MedVision, Robotics, Smart Devices, and Services.
Software designed to manage medications in remote clinics.
Robotics used to automate medication management processes.
Devices built to streamline workflows for patient care.
Services provided to enhance pharmacy technology value.
People of Omnicell
Unlock access to complete
Unlock access to complete
Software Development Team
107 people
Leadership Team
71 people
Product Management Team
44 people
Sales and Marketing
28 people
Finance and Accounting
24 people
Senior Team
22 people
Data Analysis and Operations Team
21 people
Sr. Team
12 people
Unlock access to complete
Funding Insights of Omnicell
Omnicell has successfully raised a total of $20M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Omnicell
Omnicell has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Mariko Osceola Gordon, Sutter Hill Ventures and nassau-capital.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for Omnicell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Omnicell
Omnicell has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Aesynt, Ateb and FDS Amplicare.
Investment portfolio details for Omnicell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of healthcare pharmacy services
|
Locked | Locked | 2018 | Locked | |
|
Provides pharmacy automation and information management solutions for hospitals and health systems.
|
Locked | Locked | 2013 | Locked | |
|
Medication and supply management solutions for pharmacies are provided.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Omnicell
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Omnicell
Detailed financials for Omnicell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Omnicell Comparisons
Peer comparison for Omnicell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Omnicell
Omnicell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Cureatr, Phil, RIMSYS and Healthera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Materials management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Cloud-based medication management software is provided for healthcare providers.
|
|
| Locked | Locked | Locked |
Prescription drugs refill management solutions
|
|
| Locked | Locked | Locked |
Medical device regulatory management software is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Medication adherence software is provided for pharmacies and patients.
|
Detailed competitors of Omnicell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Omnicell
Complete news archive for Omnicell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omnicell
Omnicell was founded in 1992 and raised its 1st funding round 3 years after it was founded.
Omnicell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Randy Lipps is the current CEO of Omnicell. They have also founded this company.
Omnicell is a funded company, having raised a total of $20M across 3 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Omnicell is 3,670.
Annual revenue of Omnicell is $1.11B as on Dec 31, 2024.
Omnicell is engaged in providing innovative solutions for pharmacy and medication management across various healthcare settings. The company operates in inpatient, outpatient, specialty, and retail pharmacy sectors. Solutions offered include robotics for automation, smart devices for workflow efficiency, software for supply chain visibility, and professional services to enhance operational value. Omnicells technology is designed to support health systems in achieving cost savings, improving efficiency, gaining supply chain control, and ensuring compliance. The focus remains on delivering outcomes-centric innovation to transform pharmacy care.
Omnicell's top competitors include GE Healthcare, Phil and RIMSYS.
Omnicell offers MedVision, Robotics, Smart Devices, and Services.
Yes, Omnicell is publicly traded on NASDAQ under the ticker symbol OMCL.
Omnicell has made 10 acquisitions, including Aesynt, Ateb, and FDS Amplicare.
Omnicell has 5 investors. Key investors include Mariko Osceola Gordon, Sutter Hill Ventures, nassau-capital.com, ABS Capital, and Sequoia Capital.
The ticker symbol of Omnicell is OMCL on NASDAQ.